HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA

Código QR

HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA

Guardado en:

Detalles Bibliográficos
Autor principal:	Arnon Nagler
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/17d53f7d73c34f6db566c2a3d2557f5c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

COMPARABLE OUTCOMES OF ALLOGENEIC PERIPHERAL BLOOD VERSUS BONE MARROW HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
por: AYÇA KOCA YOZGAT, et al.
Publicado: (2021)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Uroosa Ibrahim, et al.
Publicado: (2021)

EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
por: Ayse Gunay, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Ömer Faruk Bahçecioğlu, et al.
Publicado: (2021)

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients
por: Rytting ME
Publicado: (2012)

A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
por: David MARKS, et al.
Publicado: (2021)

ACUTE ABDOMEN AND ITS OUTCOMES IN CHILDREN WITH ACUTE LEUKEMIA
por: Huseyin Avnı Solgun, et al.
Publicado: (2021)

OUTCOMES OF ALLOGENEIC SC TRANSPLANT IN HEMATOLOGICAL MALIGNANCY PATIENTS USING BUSULFAN 3 (9.6 MG/KG) BASED CONDITIONING REGIMEN
por: Majed Altareb, et al.
Publicado: (2021)

Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series
por: Giancarlo Fatobene, et al.
Publicado: (2021)

Therapeutic developments in acute lymphoblastic leukemia
por: MacKenzie A, et al.
Publicado: (2012)

Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias
por: Thomas X
Publicado: (2012)

NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Özlem Tüfekçi
Publicado: (2021)

Mogamulizumab for the treatment of adult T-cell leukemia/lymphoma
por: Yoshimitsu M, et al.
Publicado: (2014)

ACUTE MEGACARYOBLASTIC LEUKEMIA IN CHILDREN: DIAGNOSTICS AND MRD MONITORING
por: Aleksandra Palladina, et al.
Publicado: (2021)

EXPERIENCE OF GLASDEGIB IN PATIENTS WITH ELDERLY ACUTE MYELOID LEUKEMIA
por: Nanişe Gizem FENER, et al.
Publicado: (2021)

POST-TREATMENT NUTRITIONAL STATUS OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
por: Akbar Akbarov, et al.
Publicado: (2021)

EVALUATION OF VACCINATION RESPONSE IN CHILDREN AFTER TREATMENT FOR ACUTE LEUKEMIA
por: Elif KILIC KONTE, et al.
Publicado: (2021)

BONE AS A SITE OF EXTRAMEDULLARY DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
por: Fatma Tuba YILDIRIM, et al.
Publicado: (2021)

Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia
por: Thomas X
Publicado: (2014)

BONE MARROW NECROSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT
por: Melike Nur Ünal, et al.
Publicado: (2021)

T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
por: Merih Reis Aras, et al.
Publicado: (2021)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
por: Anagnostou T, et al.
Publicado: (2018)

CENTRAL HYPOTHROIDISM DUE TO ACUTE LYMPHOBLASTIC LEUKEMIA WITH CENTRAL NERVOUS SYSTEM INFILTRATION
por: Dilek Kaçar, et al.
Publicado: (2021)

RETROSPECTIVE EVALUATION OF PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING VENATOCLAX-BASED TREATMENT
por: EMINE DURAK, et al.
Publicado: (2021)

Unexpected debris after post thawing donor stem cells in autologous transplantation
por: Basak Adaklı Aksoy, et al.
Publicado: (2021)

UNUSUAL METABOLIC COMPLICATIONS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: HYPERCALCEMIA, HYPERAMONEMIA, LACTIC ASIDOSIS
por: Dilek Kaçar, et al.
Publicado: (2021)

IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
por: Senem Maral, et al.
Publicado: (2021)

A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION
por: Mine KARADENIZ, et al.
Publicado: (2021)

BK-VIRUS ASSOCIATED HAEMORRHAGIC CYSTITIS CONCOMITANT WITH CHEMOTHERAPY IN AN ADOLESCENT GIRL WITH ACUTE LYMPHOBLASTIC LEUKEMIA
por: Aslı Turgutoğlu Yılmaz, et al.
Publicado: (2021)

A CHALLENGE IN PEDIATRIC ACUTE LEUKEMIA TREATMENT: UNEXPECTED, PROLONGED CYTOPENIA. IS IT BE CALLLED ‘INCOMPLETE HLH’?
por: Ersin Toret, et al.
Publicado: (2021)

CHARACTERISTICS AND OUTCOME OF T(8;21)-POSITIVE CHILDHOOD ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION'S EXPERIENCE
por: Volkan KÖSE, et al.
Publicado: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
por: Hooriyeh Shapoorian, et al.
Publicado: (2021)

INVESTIGATION OF DRUG-DRUG INTERACTIONS INVOLVING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Ayse Gunay, et al.
Publicado: (2021)

VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
por: Melda Cömert, et al.
Publicado: (2021)

MYC as therapeutic target in leukemia and lymphoma
por: Cortiguera MG, et al.
Publicado: (2015)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

IL-15 as a potential target in leukemia
por: Xiong Y, et al.
Publicado: (2015)

Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015)